MonitorDirect · GrowthWatch before adding
quant Healthcare Fund
quant Mutual FundEquity Scheme - Sectoral/ Thematic3.3 years
The scheme seeks to long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
- NAV
- 18.4988
- 30 Oct 2026
- 1Y
- +15.3%
- Trailing CAGR
- AUM
- ₹424.53 Cr
- 30 Sept 2026
- Volatility
- High
- 17.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer Aditya Birla Sun Life Business Cycle Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.3 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
1.62% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -25.2%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Sameer Kate · 1.7 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 101.8% of the portfolio.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 25%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+15.3%
- 3Y+21.1%
- 5Yn/a
- 10Yn/a
- SI+20.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+23.2%
- 3Y+13.4%
- 5Yn/a
- 10Yn/a
- Since inception
- +20.6%
- Calendar-day CAGR
- Excess 1Y
- +17.8%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 88
- Vs comparable share classes
- SIP 3Y XIRR
- +13.4%
- Simulated monthly SIP
- Worst rolling 3Y
- +18.5%
- 72 daily-ending windows
- Median rolling 3Y
- +21.2%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -25.2%
- Worst peak-to-trough
- Current
- -5.1%
- Below last peak
- Current spell
- 37 days
- Days below latest peak
- Time below peak
- +85%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 17 days
- 42 recovered episodes
- Longest recovery
- 487 days
- Trough to prior peak
13 Sept 2024 – 3 Jul 2026
Trough 3 Mar 2025 · recovered in 487 days
-25.2%
19 Feb 2024 – 21 May 2024
Trough 13 Mar 2024 · recovered in 69 days
-11.1%
23 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-10.2%
15 Sept 2023 – 17 Nov 2023
Trough 26 Oct 2023 · recovered in 22 days
-6.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
88
Vs category
100
Consistency
83
Risk-adjusted
68
Drawdown
37
Mean
75
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 27 holdings · top 10 are 101.8%.
- Top 5
- 64.6%
- Top 10
- 101.8%
- Largest holding
- 26.6%
- Effective holdings
- 6.9
Repo
Unspecified
26.6%
Glaxosmithkline Pharmaceuticals Ltd
Healthcare
9.7%
Divi's Laboratories Ltd.
Healthcare
9.6%
Zydus Lifesciences Ltd
Healthcare
9.4%
Glenmark Pharmaceuticals Limited
Healthcare
9.3%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life Business Cycle Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -0.1%
- 3Y
- +12.7%
- Vol
- 13.9%
- Max DD
- -17.8%
- Sharpe
- 0.38
- 3Y win
- +13%
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- -7.4%
- 3Y
- n/a
- Vol
- 13.9%
- Max DD
- -16.1%
- Sharpe
- 0.01
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Baroda BNP Paribas Innovation Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +4.8%
- 3Y
- n/a
- Vol
- 15.9%
- Max DD
- -22.3%
- Sharpe
- 0.45
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND
ICICI Prudential Mutual Fund
- 1Y
- -9.5%
- 3Y
- +10.3%
- Vol
- 12.6%
- Max DD
- -16.7%
- Sharpe
- 0.54
- 3Y win
- +65%
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- -0.1%
- 3Y
- +15.8%
- Vol
- 12.7%
- Max DD
- -18.4%
- Sharpe
- 0.70
- 3Y win
- +98%
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns